Dan Gibson
Jerusalem, JM 91121, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
A Cisplatin-Based Prodrug Inhibits Nucleotide Excision Repair Independently of Chromatin Accessibility to Overcome Resistance.
Journal: Biomolecules
Published: February 19, 2026
Is platinum the new gold? Re-evaluating platinum's enduring role and future potential in the era of novel ovarian cancer therapies.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 31, 2026
A New Class of Multitargeting PtIV Anticancer Agents: Prodrugs That Release PtII Drugs and Bioactive Moieties Tethered to PtIV via a Tertiary Amine.
Journal: Journal of medicinal chemistry
Published: January 15, 2026
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.
Journal: Journal of medicinal chemistry
Published: November 10, 2025
Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs.
Journal: Chemical reviews
Published: September 23, 2025
A Triple Threat Against Ovarian Cancer: Os(II)-Pt(IV)-Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction.
Journal: Angewandte Chemie (International ed. in English)
Published: August 25, 2025
Multitargeting Pt(IV) Derivatives of Cisplatin or Oxaliplatin Inhibit Tumor Growth in Mice without Inducing Neuropathic Pain.
Journal: Journal of medicinal chemistry
Published: January 08, 2025
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 11, 2024
Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.
Journal: Journal of medicinal chemistry
Published: May 31, 2024
Fluorescence-Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids.
Journal: Advanced healthcare materials
Published: January 18, 2024
Stepwise optimization of tumor-targeted dual-action platinum(iv)-gemcitabine prodrugs.
Journal: Inorganic chemistry frontiers
Published: October 05, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.
Journal: Angewandte Chemie (International ed. in English)
Published: July 27, 2023
Last Updated: 09/26/2026